Patent ID: 11972369
Assignee: THE SOTTOPELLE GROUP, LLC
Field: Medical technology (Instruments)
Classification: CPC G | IPC G

Claim 4:
5. The method of claim 1, wherein the hormone replacement therapy further comprises a delivery profile configured to deliver the therapeutically effective amount of the pharmaceutical composition over a time period that approximates what a human gonad dependent on heart rate and cardiac output may deliver, and
wherein the delivery profile is selected from a group consisting of:
a consistent delivery of the therapeutically effective amount of the pharmaceutical composition over about a 3 month to about a 5 month time period;
a consistent delivery of the therapeutically effective amount of the pharmaceutical composition over about a 4 month to about a 6 month time period;
a controlled released delivery of the therapeutically effective amount of the pharmaceutical composition over about a 3 month to about a 5 month time period;
a controlled release delivery of the therapeutically effective amount of the pharmaceutical composition over about a 4 month to about a 6 month time period; and
a combination of the delivery profile.